• News
  • Medical

Cytori to initiate clinical trial of hamstring injury treatment

San Diego-based Cytori Therapeutics (Nasdaq: CYTX) has received investigational device exemption approval from the Food and Drug Administration to begin a prospective clinical trial to evaluate the safety and feasibility of Cytori Cell Therapy as a potential treatment for hamstring injuries.

To continue reading, subscribe now
log in to your account
User Response
0 UserComments

Cytori Therapeutics

Company Website

3020 Callan Road
San Diego, CA 92121

Subscribe Today!